ArticleClinical and translational medicine2024

Safety, pharmacokinetics and efficacy of selumetinib in Chinese adult and paediatric patients with neurofibromatosis type 1 and inoperable plexiform neurofibromas: The primary analysis of a phase 1 open-label study.

Zhichao Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.